New Insights Reveal How Cancer’s Microenvironment Impacts CDK4/6 Inhibitor Effectiveness
Recent research outlined by Medical Xpress offers a deeper understanding of why CDK4/6 inhibitors, a class of drugs widely used to treat certain cancers, sometimes fail to deliver lasting benefits.…